Skip to main content
. 2023 Feb 11;91(4):957–967. doi: 10.1111/bcp.15672

TABLE 3.

Secondary PK metrics summary using noncompartmental analysis (carryover not adjusted for).

Whole Disp Whole Disp Whole Disp
25 mg (n = 16) 25 mg (n = 17) 50 mg (n = 16) 50 mg (n = 17) 100 mg (n = 16) 100 mg (n = 16)
Delamanid
T max (h) 3.81 (1.77, 5.87) 3.88 (1.77, 5.93) 3.86 (2.10, 5.90) 3.87 (1.80, 5.88) 3.82 (1.82, 5.93) 3.97 (3.75, 6.07)
C max (ng/mL) 136 (86.4, 193) 106 (66.9, 169) 192 (119, 290) 208 (106, 241) 233 (112, 424) 224 (126, 442)
AUC0‐48 (ng·h/mL) 1522 (1076, 2065) 1468 (870, 2097) 2346 (1525, 3710) 2602 (1508, 3683) 3488 (1994, 4746) 3809 (2312, 4789)
DM‐6705
T max (h) 5.84 (3.77, 48.4) 7.88 (3.8, 48.3) 5.87 (2.10, 47.1) 5.88 (3.75, 47.9) 7.82 (3.77, 48.7) 23.4 b (3.75, 48.3)
C max (ng/mL) 2.5 (1.2, 5.3) 2.8 (1.2, 5.3) 3.3 (1.3, 7.1) 2.8 (1.9, 9.5) 4.5 (3.2, 6.7) 5.2 (2.6, 8.1)
AUC0‐48 (ng·h/mL) 105 (50, 222) 106 a (50, 221) 136 (55, 312) 122 (75, 359) 184 (113, 300) 187 (98, 359)

Note: PK metrics are summarized as median (minimum, maximum).

Abbreviations: Disp, delamanid dispersed; Whole, delamanid whole tablet(s).

a

The AUC minimum of 50 was reported after excluding an incomplete PK profile (<5 h).

b

Seven participants had T max above 40 h; seven were less than 10 h; two were around 24 h, contributing to the median of 23.4 h.